Maxwell Mumbach retweeted
Excited to announce @CartographyBio's launch to bring precision immunotherapies to patients - precise therapies start with precise antigens
We’re excited to officially launch Cartography Biosciences today with $57M in initial financing. With this support, we will create a smarter roadmap for #cancer immunotherapies with our precision antigen expression atlas. 🧵
#Oncology #MedTwitter
businesswire.com/news/home/2…
Maxwell Mumbach retweeted
We’re excited to officially launch Cartography Biosciences today with $57M in initial financing. With this support, we will create a smarter roadmap for #cancer immunotherapies with our precision antigen expression atlas. 🧵
#Oncology #MedTwitter
businesswire.com/news/home/2…
Maxwell Mumbach retweeted
Immunotherapies are only as effective as their targets. Excited to share the launch of Cartography Bio, focused on finding safe and effective antigens for every cancer patient. Wonderful to work with founders @krparker @HowardYChang @MaxMumbach @CalebLareau @JeffreyVerboon
We’re excited to officially launch Cartography Biosciences today with $57M in initial financing. With this support, we will create a smarter roadmap for #cancer immunotherapies with our precision antigen expression atlas. 🧵
#Oncology #MedTwitter
businesswire.com/news/home/2…
Maxwell Mumbach retweeted
We have LIFT-OFF! Airborne Kingdom is out now for PC and Mac! Join us in the skies for a limited time discounted price of $19.99, as part of the @EpicGames Store Holiday Sale! epicgames.com/store/en-US/pr…
Maxwell Mumbach retweeted
Sailing the skies is easier when you’re fully stocked. @TheWanderingBen takes us inside resource-gathering in Airborne Kingdom. Wishlist or pre-order on @EpicGames: bit.ly/AirborneKingdomEGS
Maxwell Mumbach retweeted
We are excited to share our new multi-omic method, Spear-ATAC, which enables simultaneous read-out of CRISPR sgRNA sequences alongside droplet-based single-cell chromatin accessibility profiles! Great collaboration with @JeffreyGranja, @WJGreenleaf, and @10xGenomics!
Maxwell Mumbach retweeted
Feeling perturbed by this election? Why not take break and check out our newest work led by @Sarah_E_Pierce to profile sgRNA genotypes and chromatin accessibility in single cells!
We are excited to share our new multi-omic method, Spear-ATAC, which enables simultaneous read-out of CRISPR sgRNA sequences alongside droplet-based single-cell chromatin accessibility profiles! Great collaboration with @JeffreyGranja, @WJGreenleaf, and @10xGenomics!
Maxwell Mumbach retweeted
Excited to announce ArchR (ArchRProject.com) an R package for scATAC! Great collaboration with @doctorcorces, @Sarah_E_Pierce, @HowardYChang, and @WJGreenleaf! ArchR has a diverse toolset and can analyze upwards of a million cells on a Macbook Pro!
Maxwell Mumbach retweeted
New year, new people, new website! A belated welcome to many wonderful and brilliant new members of the lab! satpathylab.com/lab/
@StanfordPath @parkerici @CancerResearch @HumanVacProject
Maxwell Mumbach retweeted
Excited this is finally out!!! Great collaboration with Sandy Klemm, Lisa McGinnis, @10xGenomics, @gracexyzheng, @HowardYChang, Ravi Majeti, and @WJGreenleaf. We utilized multi-omic single cell data to identify malignant regulatory signatures in mixed phenotype acute leukemia.
Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia go.nature.com/2qcQBwa
Maxwell Mumbach retweeted
Excited to announce a new joint postdoc fellowship program in data science with the Parker Institute for Cancer Immunotherapy! Please share and apply! @parkerici @StanfordMed
linkedin.com/jobs/view/14876…
Maxwell Mumbach retweeted
Clonal replacement of cancer fighting T cells by checkpoint blockade. Delighted to share our latest paper. Great team work with Katie Yost, @Satpathology, Dr. Anne Chang, and @parkerici!
After anti-PD-1 therapy in basal or squamous cell carcinoma patients, the CD8+ T cell response largely consists of an expanded and exhausted repertoire of new #Tcell clones | go.nature.com/2Onv7bi #ImmunoTherapy @HowardYChang
Maxwell Mumbach retweeted
Clonal replacement of tumor-specific T cells following PD-1 blockade | Great collaboration with @KatieEYost @parkerici Anne Chang @HowardYChang
After anti-PD-1 therapy in basal or squamous cell carcinoma patients, the CD8+ T cell response largely consists of an expanded and exhausted repertoire of new #Tcell clones | go.nature.com/2Onv7bi #ImmunoTherapy @HowardYChang
congrats baby
Raw data from our TCGA ATAC-seq paper are now available through the GDC. This is in aligned bam format (hg38). Contact the GDC with any questions related to data access. Looking forward to seeing how the field makes use of this unique resource! portal.gdc.cancer.gov/
Maxwell Mumbach retweeted
HiChIRP allows a look at the role of lncRNAs in chromatin architecture. A modified 3C protocol paired with enrichment of RNA-associated chromosome conformation provides insight into the structures specific RNAs are involved in. @HowardYChang @WJGreenleaf nature.com/articles/s41592-0…
Maxwell Mumbach retweeted
APEX-seq for RNA proximity labeling across 9 cell compartments produces RNA atlas of >3200 genes + many more transcript isoforms. Insights into local translation at mito. Exciting collab. w/@HowardYChang and proud of co-first authors @F_M_Fazal & Shuo Han. biorxiv.org/content/early/20…
Maxwell Mumbach retweeted
Very proud of this work on cancer gene regulation with @JeffreyGranja @HowardYChang @WJGreenleaf @cncurtis and all of the wonderful collaborators at #TCGA and @theNCI
science.sciencemag.org/conte…
Maxwell Mumbach retweeted
In this week’s issue: mapping the chromatin landscape of human cancer, tracing the lineages of the mammalian gut community, and improving understanding of early vertebrate diversification
scim.ag/2O6xObP
Maxwell Mumbach retweeted
Starting November 1st, 2018 we will switch the current browser system (epigenomegateway.wustl.edu/b… ) to our newly developed WashU Epigenome browser. Please see details at plus.google.com/u/0/+Daofeng…